NEW YORK, Oct. 23, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Helen of Troy Limited (NASDAQ:HELE), BioPharmX Corporation (NYSE:BPMX), Fair Isaac Corporation (NYSE:FICO), Frontier Communications Corporation (NASDAQ:FTR), ICU Medical, Inc. (NASDAQ:ICUI), and Darling Ingredients Inc. (NYSE:DAR), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
HELE DOWNLOAD: http://Fundamental-Markets.com/register/?so=HELE
BPMX DOWNLOAD: http://Fundamental-Markets.com/register/?so=BPMX
FICO DOWNLOAD: http://Fundamental-Markets.com/register/?so=FICO
FTR DOWNLOAD: http://Fundamental-Markets.com/register/?so=FTR
ICUI DOWNLOAD: http://Fundamental-Markets.com/register/?so=ICUI
DAR DOWNLOAD: http://Fundamental-Markets.com/register/?so=DAR
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine Helen of Troy Limited (NASDAQ:HELE), BioPharmX Corporation (NYSE:BPMX), Fair Isaac Corporation (NYSE:FICO), Frontier Communications Corporation (NASDAQ:FTR), ICU Medical, Inc. (NASDAQ:ICUI), and Darling Ingredients Inc. (NYSE:DAR) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 19th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
HELEN OF TROY LIMITED (HELE) REPORT OVERVIEW
Helen of Troy's Recent Financial Performance
For the three months ended August 31st, 2018 vs August 31st, 2017, Helen of Troy reported revenue of $393.55MM vs $344.95MM (up 14.09%) and analysts estimated basic earnings per share $1.67 vs $0.33 (up 406.06%). For the twelve months ended February 28th, 2018 vs February 28th, 2017, Helen of Troy reported revenue of $1,489.75MM vs $1,406.68MM (up 5.91%) and analysts estimated basic earnings per share $1.64 vs $5.11 (down 67.91%). Analysts expect earnings to be released on January 14th, 2019. The report will be for the fiscal period ending November 30th, 2018. The reported EPS for the same quarter last year was $2.38. The estimated EPS forecast for the next fiscal year is $7.45 and is expected to report on April 25th, 2019.
To read the full Helen of Troy Limited (HELE) report, download it here: http://Fundamental-Markets.com/register/?so=HELE
-----------------------------------------
BIOPHARMX CORPORATION (BPMX) REPORT OVERVIEW
BioPharmX's Recent Financial Performance
For the three months ended July 31st, 2018 vs July 31st, 2017, BioPharmX reported revenue of $0.02MM vs $0.02MM (up 41.18%) and analysts estimated basic earnings per share -$0.02 vs -$0.05. For the twelve months ended January 31st, 2018 vs January 31st, 2017, BioPharmX reported revenue of $0.07MM vs $0.10MM (down 27.00%) and analysts estimated basic earnings per share -$0.19 vs -$0.52. Analysts expect earnings to be released on December 6th, 2018. The report will be for the fiscal period ending October 31st, 2018. Reported EPS for the same quarter last year was -$0.05.
To read the full BioPharmX Corporation (BPMX) report, download it here: http://Fundamental-Markets.com/register/?so=BPMX
-----------------------------------------
FAIR ISAAC CORPORATION (FICO) REPORT OVERVIEW
Fair Isaac's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Fair Isaac reported revenue of $259.51MM vs $230.99MM (up 12.35%) and analysts estimated basic earnings per share $1.09 vs $0.82 (up 32.93%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, Fair Isaac reported revenue of $932.17MM vs $881.36MM (up 5.77%) and analysts estimated basic earnings per share $4.16 vs $3.52 (up 18.18%). Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $1.25. The estimated EPS forecast for the next fiscal year is $5.70 and is expected to report on November 7th, 2018.
To read the full Fair Isaac Corporation (FICO) report, download it here: http://Fundamental-Markets.com/register/?so=FICO
-----------------------------------------
FRONTIER COMMUNICATIONS CORPORATION (FTR) REPORT OVERVIEW
Frontier Communications' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Frontier Communications reported revenue of $2,162.00MM vs $2,304.00MM (down 6.16%) and basic earnings per share -$0.92 vs -$9.20. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Frontier Communications reported revenue of $9,128.00MM vs $8,896.00MM (up 2.61%) and analysts estimated basic earnings per share -$25.99 vs -$7.61. Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.94. The estimated EPS forecast for the next fiscal year is -$0.85 and is expected to report on February 26th, 2019.
To read the full Frontier Communications Corporation (FTR) report, download it here: http://Fundamental-Markets.com/register/?so=FTR
-----------------------------------------
ICU MEDICAL, INC. (ICUI) REPORT OVERVIEW
ICU Medical's Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, ICU Medical reported revenue of $360.46MM vs $331.51MM (up 8.73%) and analysts estimated basic earnings per share $1.53 vs -$1.87. For the twelve months ended December 31st, 2017 vs December 31st, 2016, ICU Medical reported revenue of $1,292.61MM vs $379.37MM (up 240.72%) and analysts estimated basic earnings per share $3.50 vs $3.90 (down 10.26%). Analysts expect earnings to be released on November 8th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.01. The estimated EPS forecast for the next fiscal year is $9.13 and is expected to report on March 7th, 2019.
To read the full ICU Medical, Inc. (ICUI) report, download it here: http://Fundamental-Markets.com/register/?so=ICUI
-----------------------------------------
DARLING INGREDIENTS INC. (DAR) REPORT OVERVIEW
Darling Ingredients' Recent Financial Performance
For the three months ended June 30th, 2018 vs June 30th, 2017, Darling Ingredients reported revenue of $846.65MM vs $894.93MM (down 5.40%) and analysts estimated basic earnings per share -$0.18 vs $0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Darling Ingredients reported revenue of $3,662.25MM vs $3,391.93MM (up 7.97%) and analysts estimated basic earnings per share $0.78 vs $0.62 (up 25.81%). Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.05. The estimated EPS forecast for the next fiscal year is $0.93 and is expected to report on February 26th, 2019.
To read the full Darling Ingredients Inc. (DAR) report, download it here: http://Fundamental-Markets.com/register/?so=DAR
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.